Elutia share price today

(ELUT)

Elutia share price is $4.84 & ₹411.28 as on 21 Dec 2024, 2.30 'hrs' IST

$4.84

▲

1.31

(37.11%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Elutia share price in Dollar and Rupees. Guide to invest in Elutia from India. Also see the sentimental analysis on Indian investors investing in Elutia. Get details on the Indian mutual funds that are investing in Elutia. Get Analyst recommendations and forecasts along with all the Elutia's financials.

Elutia share price movements

Today's Low: $3.49
Today's High: $4.84
$4.84
27.89%
Downside
Day's Volatility :27.89%
Upside
0.0%
52 Weeks Low: $1.96
52 Weeks High: $5.24
$4.84
59.5%
Downside
52 Weeks Volatility :62.6%
Upside
7.63%

Elutia Returns

Period	Elutia Inc	Index (Russel 2000)
3 Months	25.71%	0.0%
6 Months	23.79%	0.0%
1 Year	137.25%	0.0%
3 Years	240.01%	-19.7%

Elutia Key Statistics

in dollars & INR

Previous Close	$3.53
Open	$3.52
Today's High	$4.84
Today's Low	$3.49
Market Capitalization	$122.0M
Today's Volume	$167.7K
52 Week High	$5.24
52 Week Low	$1.96
Revenue TTM	$25.0M
EBITDA	$-18.7M
Earnings Per Share (EPS)	$-2.35
Profit Margin	-261.08%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Elutia from India?

It is very easy for Indian residents to invest directly in Elutia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Elutia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Elutia or ELUT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Elutia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Elutia shares which would translate to 0.176 fractional shares of Elutia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Elutia, in just a few clicks!

Returns in Elutia for Indian investors in Rupees

Investment Value

₹1,00,000

Elutia investment value today

Current value as on today

₹2,39,451

Returns

₹1,39,451

(+139.45%)

Returns from Elutia Stock

₹1,37,255 (+137.25%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Elutia

-25%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Elutia on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -25% less investors are searching Elutia in the last 30 days versus the previous period.

Analyst Recommendation on Elutia

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Elutia(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Elutia

What analysts predicted

Upside of 85.95%

Current:

$4.84

Target:

$9.00

Insights on Elutia

Price Movement
In the last 7 days, ELUT stock has moved up by 16.9%
Decreasing Revenue
Revenue is down for the last 3 quarters, 6.69M → 5.92M (in $), with an average decrease of 5.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -28.18M → 1.28M (in $), with an average increase of 2291.3% per quarter

Elutia Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$42.9M	-
Net Income	$-11.9M	-
Net Profit Margin	-27.83%	-

	FY20	Y/Y Change
Revenue	$42.7M	↓ 0.51%
Net Income	$-21.8M	↑ 82.8%
Net Profit Margin	-51.13%	↓ 23.3%

	FY21	Y/Y Change
Revenue	$47.4M	↑ 11.03%
Net Income	$-24.8M	↑ 13.78%
Net Profit Margin	-52.4%	↓ 1.27%

	FY22	Y/Y Change
Revenue	$23.8M	↓ 49.68%
Net Income	$-32.9M	↑ 32.48%
Net Profit Margin	-137.94%	↓ 85.54%

	FY23	Y/Y Change
Revenue	$24.7M	↑ 3.76%
Net Income	$-37.7M	↑ 14.47%
Net Profit Margin	-152.18%	↓ 14.24%

	Q2 FY23	Q/Q Change
Revenue	$10.3M	↓ 21.1%
Net Income	$-10.6M	↑ 33.2%
Net Profit Margin	-103.16%	↓ 42.06%

	Q3 FY23	Q/Q Change
Revenue	$6.1M	↓ 40.49%
Net Income	$-9.7M	↓ 8.23%
Net Profit Margin	-159.08%	↓ 55.92%

	Q4 FY23	Q/Q Change
Revenue	$5.9M	↓ 4.11%
Net Income	$-15.3M	↑ 57.14%
Net Profit Margin	-260.7%	↓ 101.62%

	Q1 FY24	Q/Q Change
Revenue	$6.7M	↑ 13.94%
Net Income	$-18.0M	↑ 17.48%
Net Profit Margin	-268.81%	↓ 8.11%

	Q2 FY24	Q/Q Change
Revenue	$6.3M	↓ 6.02%
Net Income	$-28.2M	↑ 56.61%
Net Profit Margin	-447.94%	↓ 179.13%

	Q3 FY24	Q/Q Change
Revenue	$5.9M	↓ 5.87%
Net Income	$1.3M	↓ 104.56%
Net Profit Margin	21.72%	↑ 469.66%

	FY19	Y/Y Change
Profit	$19.8M	-

	FY20	Y/Y Change
Profit	$20.6M	↑ 4.01%

	FY21	Y/Y Change
Profit	$19.0M	↓ 7.49%

	FY22	Y/Y Change
Profit	$11.6M	↓ 38.81%

	FY23	Y/Y Change
Profit	$11.1M	↓ 5.03%

	Q2 FY23	Q/Q Change
Profit	$980.0K	↓ 84.52%

	Q3 FY23	Q/Q Change
Profit	$2.8M	↑ 189.9%

	Q4 FY23	Q/Q Change
Profit	$2.1M	↓ 25.24%

	Q1 FY24	Q/Q Change
Profit	$2.8M	↑ 33.85%

	Q2 FY24	Q/Q Change
Profit	$2.8M	↓ 1.55%

	Q3 FY24	Q/Q Change
Profit	$2.7M	↓ 2.07%

	FY19	Y/Y Change
Operating Cash Flow	$-7.2M	-
Investing Cash Flow	$-577.0K	-
Financing Cash Flow	$8.0M	-

	FY20	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 85.95%
Investing Cash Flow	$-640.0K	↑ 10.92%
Financing Cash Flow	$51.0M	↑ 539.39%

	FY21	Y/Y Change
Operating Cash Flow	$-15.6M	↑ 16.25%
Investing Cash Flow	$-369.0K	↓ 42.34%
Financing Cash Flow	$6.9M	↓ 86.51%

	FY22	Y/Y Change
Operating Cash Flow	$-21.9M	↑ 40.24%
Investing Cash Flow	$-540.0K	↑ 46.34%
Financing Cash Flow	$9.0M	↑ 30.8%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.4M	↑ 0.0%
Investing Cash Flow	$-85.0K	↑ 0.0%
Financing Cash Flow	$-19.0K	↑ 0.0%

Elutia Technicals Summary

Sell

Neutral

Buy

Elutia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Elutia Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Elutia Inc	10.0%	23.79%	137.25%	240.01%	240.01%
Stryker Corporation	-6.55%	7.53%	22.55%	38.08%	71.54%
Boston Scientific Corp.	-2.79%	15.96%	59.12%	110.98%	96.7%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.35%	-41.48%	-5.43%
Abbott Laboratories	-2.58%	8.48%	4.77%	-17.81%	30.77%
Medtronic Plc	-4.38%	-0.01%	-1.09%	-20.04%	-28.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Elutia Inc	NA	NA	NA	0.0	0.0	-0.29	NA	-1.66
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Elutia Inc	Buy	$122.0M	240.01%	NA	-261.08%
Stryker Corporation	Buy	$136.1B	71.54%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.7%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-5.43%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.77%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.85%	24.46	12.06%

About Elutia

aziyo was created by highcape partners and tissue banks international with the mission of restoring health and mobility to the greatest number of patients. our vision for aziyo is to impact healthcare as the premier partner in innovation of new solutions that realize the potential of regenerative medicine. honoring the gift from those who selfishly give the precious gift of donation to those who receive it, we are committed to honoring the lives of these brave individuals and their families everyday. whether you need a traditional bone graft, a processed osteobiologic, or a custom musculoskeletal tissue product, aziyo is committed to innovating new solutions that help fulfill the promise of regenerative medicine. at aziyo, we foster a collaborative environment where we deliver best-in-class solutions and operational excellence to our customers each and every day.

Organization	Elutia
Employees	54
CEO	Dr. C. Randal Mills Ph.D.
Industry	Miscellaneous

Management People of Elutia

Name	Title
Dr. C. Randal Mills Ph.D.	Co-Founder, President & CEO and Director
Mr. Matthew B. Ferguson	Chief Financial Officer
Dr. Michelle LeRoux Williams Ph.D.	Chief Scientific Officer
Ms. Courtney Guyer	Vice President of Marketing
Dr. Sonali Fonseca Ph.D.	VP & Head of Emerging Businesses
Mr. Jeffry D. Hamet	Senior VP of Finance, Treasurer & Secretary

Important FAQs about investing in Elutia from India :

What is Elutia share price today?

Elutia share price today stands at $4.84, Open: $3.52 ; Previous Close: $3.53 ; High: $4.84 ; Low: $3.49 ; 52 Week High: $5.24 ; 52 Week Low: $1.96. The stock opens at $3.52, after a previous close of $3.53. The stock reached a daily high of $4.84 and a low of $3.49, with a 52-week high of $5.24 and a 52-week low of $1.96.

Can Indians buy Elutia shares?

Yes, Indians can invest in the Elutia (ELUT) from India.

With INDmoney, you can buy Elutia at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Elutia at zero transaction cost.

How can I buy Elutia shares from India?

It is very easy to buy Elutia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Elutia be purchased?

Yes, you can buy fractional shares of Elutia with INDmoney app.

What are the documents required to start investing in Elutia stocks?

To start investing in Elutia, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.